» Articles » PMID: 25560714

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD Statement

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2015 Jan 7
PMID 25560714
Citations 1104
Authors
Affiliations
Soon will be listed here.
Abstract

Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed. The Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Initiative developed a set of recommendations for the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, health care professionals, and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors. The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document. To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statement.org).

Citing Articles

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab.

Gairing S, Mildenberger P, Gile J, Artusa F, Scheiner B, Leyh C JHEP Rep. 2025; 7(3):101295.

PMID: 40059970 PMC: 11889551. DOI: 10.1016/j.jhepr.2024.101295.


Leveraging small-sample machine learning for rigorous prediction of JOA recovery in cervical spondylotic myelopathy patients: insights from imaging parameters and modeling strategies.

Li Z, Feng Z, Yang H, Hai Y Eur Spine J. 2025; .

PMID: 40053078 DOI: 10.1007/s00586-025-08763-7.


Genetics, primary care records and lifestyle factors for short-term dynamic risk prediction of colorectal cancer: prospective study of asymptomatic and symptomatic UK Biobank participants.

Ip S, Harrison H, Usher-Smith J, Barclay M, Tyrer J, Dennis J BMJ Oncol. 2025; 4(1):e000336.

PMID: 40046831 PMC: 11880779. DOI: 10.1136/bmjonc-2024-000336.


Early Risk Stratification of Patients After Successfully Resuscitated Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation-The Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation (TOMAHAWK) Risk Score.

Thevathasan T, Spoormans E, Akin I, Fuernau G, Tebbe U, Haeusler K Crit Care Explor. 2025; 7(3):e1221.

PMID: 40042208 PMC: 11884833. DOI: 10.1097/CCE.0000000000001221.


Artificial intelligence and pediatric acute kidney injury: a mini-review and white paper.

Hu J, Raina R Front Nephrol. 2025; 5:1548776.

PMID: 40041609 PMC: 11876175. DOI: 10.3389/fneph.2025.1548776.